Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma

Environmental and Molecular Mutagenesis

Volumn 50, Issue 5, 2009, Pages 421-430

  Crous Bou, Marta ^a,b   Porta, Miquel ^a,b   López, Tomàs ^a,b   Jariod, Manel ^c   Malats, Ńuria ^a,d   Morales, Eva ^a,b   Guarner, Luisa ^a,e   Rifà, Juli ^f   Carrato, Alfredo ^g   Real, Francisco X ^a,d,h  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^h UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Alcohol drinking; Alcoholic beverages; Etiology; Pancreatic ductal adenocarcinoma; Pancreatic neoplasm; Ras genes

Indexed keywords

K RAS PROTEIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HOSPITAL ADMISSION; HUMAN; LIFE HISTORY; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREATITIS; SMOKING; AGED; CHEMICALLY INDUCED DISORDER; CODON; DRINKING BEHAVIOR; DRUG EFFECT; GENETICS; INTERVIEW; MIDDLE AGED; MUTATION; ONCOGENE RAS; PANCREAS CARCINOMA; RISK; STATISTICAL MODEL;

ORA;

AGED; ALCOHOL DRINKING; CARCINOMA, PANCREATIC DUCTAL; CODON; FEMALE; GENES, RAS; HUMANS; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION; ODDS RATIO; SMOKING;

EID: 67549150899     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20483     Document Type: Article

References (56)

1. Alguacil J, Porta M, Kauppinen T, Malats N, Kogevinas M, Carrato A; PANKRAS II Study Group. 2003. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer. Int J Cancer 107:635-641. (Pubitemid 37296126)
2. Alguacil J, Porta M, Malats, Kauppinen T, Kogevinas M, Benavides FG, Partanen T, Carrato A. 2002. Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer. Carcinogenesis 23:101-106. (Pubitemid 34213558)
3. Armitage P, Berry G, Matthews JNS. 2002. Statistical Methods in Medical Research, 4th ed. Oxford: Blackwell.
4. Bardeesy N, DePinho RA. 2002. Pancreatic cancer biology and genetics. Nat Rev Cancer 2:897-909.
5. Begg CB, Zhang ZF. 1994. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 3:173-175. (Pubitemid 124000417)
6. Blanck HM, Tolbert PE, Hoppin JA. 1999. Patterns of genetic alterations in pancreatic cancer: A pooled analysis. Environ Mol Mutagen 33:111-122. (Pubitemid 29172232)
7. Bland M. 1987. An Introduction to Medical Statistics. Oxford: Oxford Medical Publications. pp 241-265.
8. Boffetta P, Hashibe M. 2006. Alcohol and cancer. Lancet Oncol 7:149-156.
9. Bongaerts BW, de Goeij AF, van den Brandt PA, Weijenberg MP. 2006. Alcohol and the risk of colon and rectal cancer with mutations in the K-ras gene. Alcohol 38:147-154. (Pubitemid 44189160)
10. Crous-Bou M, Porta M, López T, Jariod M, Malats N, Alguacil J, Morales E, Fernandez E, Corominas JM, Carrato A, Guarner L, Real FX. 2007. Lifetime history of tobacco consumption and K- ras mutations in exocrine pancreatic cancer. Pancreas 35:135-141. (Pubitemid 47075567)
11. Crous-Bou M, Porta M, Morales E, López T, Carrato A, Puigdomènech E, Real FX. Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: A hypothesis-generating study. Cancer Causes Control; PMID: 19083106 (in press).
12. Ekbom A, Hunter D. 2002.Pancreatic cancer. In: Adami HO, Hunter D,Trichopoulos D, editors. Textbook of Cancer Epidemiology. New York:Oxford University Press. pp 233-247.
13. Gavaldà L, Porta M, Malats N, Piñol JL, Fernandez E, Maguire A, Cortès I, Carrillo E, Marrugat M, Rifà J. 1995. Agreement between information supplied by the patient and a family member on medical history, consumption of tobacco, alcohol and coffee and diet in cancer of the exocrine pancreas and extrahepatic biliary tract. Gac Sanit 9:334-342.
14. Go VL, Gukovskaya A, Pandol SJ. 2005. Alcohol and pancreatic cancer. Alcohol 35:205-211.
15. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D. 2007. Risk factors for pancreatic cancer: Case-control study. Am J Gastroenterol 102:2696-2707. (Pubitemid 350179330)
16. Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. 2006. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 20:1218-1249. (Pubitemid 43727584)
17. IARC. Consumption of Alcoholic Beverages.IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol.96. Lyon: International Agency for Research on Cancer (in press). Available at http://monographs.iarc.fr/ENG/ Meetings/96-alcohol.pdf.
18. IARC. 1988. Alcohol Drinking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol.44. Lyon: International Agency for Research on Cancer.
19. Li D, Jiao L, Porta M. 2005. Epidemiology. In: von Hoff DD,Evans DB, Hruban RH, editors. Pancreatic Cancer. Boston: Jones & Bartlett. pp 103-117.
20. Lo AC, Soliman AS, El-Ghawalby N, Abdel-Wahab M, Fathy O, Khaled HM, Omar S, Hamilton SR, Greenson JK, Abbruzzese JL. 2007. Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk. Pancreas 35:120-129. (Pubitemid 47075565)
21. Lowenfels AB, Maisonneuve P. 2006. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 20:197-209.
22. Maitra A, Adsay NV, Argani P, Iacobuzio-Donahue C, De Marzo A, Cameron JL, Yeo CJ, Hruban RH. 2003. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 16:902-912. (Pubitemid 37152020)
23. Malats N, Porta M, Corominas JM, Piñol JL, Rifà J, Real FX. 1997. Kiras mutations in exocrine pancreatic cancer: Association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators. Int J Cancer 70:661-667. (Pubitemid 27158444)
24. Malats N, Casals T, Porta M, Guarner L, Estivill X, Real FX. 2001. The cystic fibrosis transmembrane regulator (CFTR) △F508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreas cancer. Gut 48:70-74. (Pubitemid 32042644)
25. Malumbres M, Barbacid M. 2003. RAS oncogenes: The first 30 years. Nat Rev Cancer 3:459-465.
26. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. 2001. Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev 10:429-437. (Pubitemid 32701627)
27. Morales E, Porta M, Vioque J, López T, Mendez MA, Pumarega JA, Malats N, Crous-Bou M, Ngo J, Rifà J, Carrato A, Guarner L, Corominas JM, Real FX;for the PANKRAS II Study Group. 2007. Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. J Epidemiol Community Health 61:641-649.
28. Otsuki M, Tashiro M. 2007. Chronic pancreatitis and pancreatic cancer, lifestyle-related diseases. Intern Med 46:109-113. (Pubitemid 46157701)
29. Piegorsch WW, Weinberg CR, Taylor JA. 1994. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med 13:153-162. (Pubitemid 24017109)
30. Porta M, Malats N, Piñol JL, Rifà J, Andreu M, Real FX. 1994. Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. J Clin Epidemiol 47:1069-1079. Porta M, Malats N, Jariod M, Grimalt JO, Rifà J, Carrato A, Guarner L, Salas A, Santiago-Silva M, Corominas JM, Andreu M, Real FX. 1999a. Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. Lancet 354:2125-2129. (Pubitemid 24268917)
31. Porta M, Malats N, Guarner L, Carrato A, Rifà J, Salas A, Corominas JM, Andreu M, Real FX. 1999b. Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. J Epidemiol Community Health 53:702-709. (Pubitemid 29486177)
32. Porta M, Costafreda S, Malats N, Guarner L, Soler M, Gubern JM, García-Olivares E, Andreu M, Salas A, Corominas JM, Alguacil J, Carrato A, Rifà J, Real FX. 2000a. Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology. Eur J Epidemiol 16:533-541. (Pubitemid 30760833)
33. Porta M, Malats N, Alguacil J, Ruiz L, Jariod M, Carrato A, Guarner L. 2000b. Coffee, pancreatic cancer, and K-ras mutations: Updating the research agenda. J Epidemiol Community Health 54:656-659. (Pubitemid 30639396)
34. Porta M, Malats N, Corominas JM, Rifà J, Piñol JL, Real FX. 2002. Generalizing molecular results arising from incomplete biological samples: Expected bias and unexpected findings. Ann Epidemiol 12:7-14. (Pubitemid 34003066)
35. Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A, Ruiz L, Jariod M, Costafreda S, Coll S, Alguacil J, Corominas JM, Solà R, Salas A, Real FX. 2005. Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stage. Clin Transl Oncol 7:189-197.
36. Pöschl G, Stickel F, Wang XD, Seitz HK. 2004. Alcohol and cancer: Genetic and nutritional aspects. Proc Nutr Soc 63:65-71. (Pubitemid 38543874)
37. Real FX, Malats N, Lesca G, Porta M, Chopin S, Lenoir GM, Sinilnikova O. 2002. Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreas cancer. Gut 50:653-657. (Pubitemid 34407492)
38. Real FX, Cibrián-Uhalte E, Martinelli P. 2008. Pancreatic cancer development and progression: Remodeling the model. Gastroenterology 135:724-728.
39. Rosenbaum PR. 2004. The case-only odds ratio as a causal parameter. Biometrics 60:233-240. (Pubitemid 38392636)
40. Rothman KJ, Greenland S, Lash TL. 2008. Modern Epidemiology, 3rd ed. Philadelphia: Lippincott Willian & Wilkins.
41. Salaspuro MP. 2003. Alcohol consumption and cancer of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 17:679-694. (Pubitemid 37554741)
42. Sarkola T, Iles MR, Kohlenberg-Mueller K, Eriksson CJ. 2002. Ethanol, acetaldehyde, acetate, and lactate levels after alcohol intake in white men and women: Effect of 4-methylpyrazole. Alcohol Clin Exp Res 26:239-245. (Pubitemid 34157760)
43. Seitz HK, Stickel F. 2007. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7:599-612.
44. Seitz HK, Simanowski UA, Garzon FT, Rideout JM, Peters TJ, Koch A, Berger MR, Einecke H, Maiwald M. 1990. Possible role of acetaldehyde in ethanol-related rectal cocarcinogenesis in the rat. Gastroenterology 98:406-413. (Pubitemid 20037924)
45. Seitz HK, Matsuzaki S, Yokoyama A, Homann N, Väkeväinen S, Wang XD. 2001. Alcohol and cancer. Alcohol Clin Exp Res 25:137-143.
46. Simanowski UA, Suter P, Russell RM, Heller M, Waldherr R, Ward R, Peters TJ, Smith D, Seitz HK. 1994. Enhancement of ethanol induced rectal mucosal hyper regeneration with age in F344 rats. Gut 35:1102-1106. (Pubitemid 24244267)
47. Simanowski UA, Homann N, Knühl M, Arce L, Waldherr R, Conradt C, Bosch FX, Seitz HK. 2001. Increased rectal cell proliferation following alcohol abuse. Gut 49:418-422. (Pubitemid 32802578)
48. Slattery ML, Curtin K, Anderson K, Ma KN, Edwards S, Leppert M, Potter J, Schaffer D, Samowitz WS. 2000. Associations between dietary intake and Ki-ras mutations in colon tumors: A population- based study. Cancer Res 60:6935-6941. (Pubitemid 32059166)
49. Soler M, Porta M, Malats N, Guarner L, Costafreda S, Gubern JM, García-Olivares E, Andreu M, Real FX. 1998. Learning from casereports: Diagnostic issues in an epidemiologic study of pancreatic cancer. J Clin Epidemiol 51:1215-1221. (Pubitemid 29009521)
50. Soler M, Malats N, Porta M, Fernandez E, Guarner L, Maguire A, Pinõl JL, Rifà J, Carrato A. 1999. Medical conditions in patients with pancreatic and biliary diseases: Validity and agreement between data from questionnaires and medical records. Dig Dis Sci 44:2469-2477. Soliman AS, Bondy M, Webb CR, Schottenfeld D, Bonner J, El-Ghawalby N, Soultan A, Abdel-Wahab M, Fathy O, Ebidi G, Zhang Q, Greenson JK, Abbruzzese JL, Hamilton SR. 2006. Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients. Int J Cancer 119:1455-1461. (Pubitemid 30027363)
51. Vineis P, Malats N, Porta M, Real FX. 1999. Human cancer, carcinogenic exposures and mutation spectra. Mutat Res 436:185-194. (Pubitemid 129750348)
52. Wang M, Yu N, Chen L, Villalta PW, Hochalter JB, Hecht SS. 2006. Identification of an acetaldehyde adduct in human liver DNA, quantitation as N2-ethyldeoxyguanosine. Chem Res Toxicol 19:319-324. (Pubitemid 43306922)
53. Weiderpass E, Partanen T, Kaaks R, Vainio H, Porta M, Kauppinen T, Ojajärvi A, Boffetta P, Malats N. 1998. Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health 24:165-174. (Pubitemid 28369431)
54. Welsch T, Kleeff J, Seitz HK, Büchler P, Friess H, Büchler MW. 2006. Update on pancreatic cancer and alcohol-associated risk. J Gastroenterol Hepatol 21:69-75. (Pubitemid 44266555)
55. Yang AL, Vadhavkar S, Singh G, Omary MB. 2008. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med 168:649-656.
56. Ye W, Lagergren J, Weiderpass E, Nyrén O, Adami HO, Ekbom A. 2002. Alcohol abuse and the risk of pancreatic cancer. Gut 51:236-239. (Pubitemid 34791453)